InvestorsHub Logo
Followers 1171
Posts 34538
Boards Moderated 0
Alias Born 03/26/2007

Re: None

Tuesday, 05/25/2021 9:08:27 AM

Tuesday, May 25, 2021 9:08:27 AM

Post# of 13742
Great 1st QR with Medolife CEO Dr. Arthur Mikaelian...

Medolife Rx Reports First Quarter 2021 Financial and Operational Results, Schedules Conference Call with Investment Community


https://finance.yahoo.com/news/medolife-rx-reports-first-quarter-130000990.html

First Quarter 2021 Highlights:

Total revenue generated was USD $318,807;

Gross margins remained above 90%;

Cash on hand at the end of the quarter was over USD $300,000, a substantial increase when compared to the same period in the prior year;

Various positive updates on preclinical studies completed on its lead drug candidate Escozine® demonstrating safety and efficacy of the product;

Preparation for response to Pre-Investigational New Drug (IND) filing with the U.S. Food and Drug Administration (FDA);

Expansion of first-of-its-kind scorpion reservation and research facility in the Dominican Republic (DR), preparing for demand created by product registration of Escozine® in the region;

Rebranding efforts on nutraceutical product lines focused on major markets such as beauty, wellness and nutritional supplements;


Participate and Ask a Question during the CC.
https://zoom.us/webinar/register/WN_gfcQmH6PQCujWCOQjIRwyA

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.